Intrinsic and extrinsic mechanisms of oocyte loss.
A great deal of evolutionary conservation has been found in the control of oocyte development, from invertebrates to women. However, little is known of mechanisms that control oocyte loss over time. Oocyte loss is often assumed to be a result of oocyte-intrinsic deficiencies or damage. In fruit flies, starvation results in halted oocyte production by germline stem cells and induces oocyte loss midway through development. When we fed wild-type flies the bacterial compound Rapamycin (RAP) to mimic starvation, production of new oocytes continued, but mid-stage loss sterilized the animals. Surprisingly, follicle cell invasion and phagocytosis of the oocyte preceded any signs of germ cell death. RAP-induced egg chamber loss was prevented when RAP receptor FKBP12 was knocked down specifically in follicle cells. Oogenesis continued past the mid-stages, and these mutants continued to lay embryos that could develop into normal adults. Hence, intact healthy oocytes can be destroyed by somatic cells responding to extrinsic stimuli. We termed this process inducible somatic oocyte destruction. RAP treatment of mouse follicles in vitro resulted in phagocytic uptake of the oocyte by granulosa cells as seen in flies. We hypothesize that extrinsic modes of oocyte loss occur in mammals.
Thomson
Travis C
TC
Department of Obstetrics, Gynecology & Reproductive Sciences, Division of Reproductive Endocrinology and Infertility, Yale School of Medicine, 333 Cedar Street FMB 329F, New Haven, CT 06520, USA.
Fitzpatrick
Katherine E
KE
Johnson
Joshua
J
D000818:Animals; D001483:Base Sequence; D017124:Conserved Sequence; D004331:Drosophila melanogaster / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D005260:Female; D006801:Humans; D051379:Mice; D009865:Oocytes / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism; D009866:Oogenesis / Q000502:physiology; D006080:Ovarian Follicle / Q000187:drug effects / Q000254:growth & development; D010587:Phagocytosis / Q000187:drug effects; D020123:Sirolimus / Q000494:pharmacology*; D058570:TOR Serine-Threonine Kinases / Q000235:genetics
D058570:TOR Serine-Threonine Kinases; D020123:Sirolimus